Variant report

Variant	nsv876289
Chromosome Location	chr3:236759-310747
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:468)
CpG islands
(count:1221)
Chromatin interactive
region (count:4)
LncRNA
region (count:24)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:468 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr3:291259-291870	HepG2	liver:	n/a	n/a
2	ARID3A	chr3:305517-307368	HepG2	liver:	n/a	n/a
3	ATF2	chr3:254017-254518	GM12878	blood:	n/a	n/a
4	ATF2	chr3:254098-254530	GM12878	blood:	n/a	n/a
5	ATF3	chr3:306304-306760	A549	lung:	n/a	n/a
6	BACH1	chr3:271174-271333	K562	blood:	n/a	n/a
7	BACH1	chr3:238302-238499	H1-hESC	embryonic stem cell:	n/a	n/a
8	BACH1	chr3:238826-240389	H1-hESC	embryonic stem cell:	n/a	n/a
9	BATF	chr3:259675-259847	GM12878	blood:	n/a	n/a
10	BATF	chr3:254085-254416	GM12878	blood:	n/a	n/a
11	BCL3	chr3:306315-306750	A549	lung:	n/a	n/a
12	BCL3	chr3:306168-306863	A549	lung:	n/a	chr3:306285-306294 chr3:306282-306291
13	BHLHE40	chr3:306286-306823	HepG2	liver:	n/a	n/a
14	BHLHE40	chr3:260829-261058	GM12878	blood:	n/a	n/a
15	BHLHE40	chr3:260263-260618	GM12878	blood:	n/a	n/a
16	BRCA1	chr3:306406-306600	HepG2	liver:	n/a	n/a
17	BRCA1	chr3:306367-306903	Hela-S3	cervix:	n/a	n/a
18	CCNT2	chr3:238979-239034	K562	blood:	n/a	n/a
19	CEBPB	chr3:306264-306781	A549	lung:	n/a	chr3:306309-306322 chr3:306463-306480
20	CEBPB	chr3:284758-286178	IMR90	lung:	n/a	chr3:284916-284933 chr3:285984-286001 chr3:284887-284900
21	CEBPB	chr3:242488-242808	A549	lung:	n/a	n/a
22	CEBPB	chr3:306097-307016	A549	lung:	n/a	chr3:306309-306322 chr3:306463-306480
23	CEBPB	chr3:291583-291816	HepG2	liver:	n/a	chr3:291705-291716
24	CEBPB	chr3:242440-242811	HepG2	liver:	n/a	n/a
25	CEBPB	chr3:291542-291836	HepG2	liver:	n/a	chr3:291705-291716
26	CEBPB	chr3:306278-306814	A549	lung:	n/a	chr3:306309-306322 chr3:306463-306480
27	CEBPB	chr3:306177-307012	Hela-S3	cervix:	n/a	chr3:306309-306322 chr3:306463-306480
28	CEBPB	chr3:243976-244300	IMR90	lung:	n/a	chr3:244109-244120
29	CEBPB	chr3:306266-306559	MCF-7	breast:	n/a	chr3:306309-306322 chr3:306463-306480
30	CEBPB	chr3:242447-242817	IMR90	lung:	n/a	n/a
31	CEBPB	chr3:271018-271333	H1-hESC	embryonic stem cell:	n/a	chr3:271305-271317
32	CEBPB	chr3:306302-306622	MCF-7	breast:	n/a	chr3:306309-306322 chr3:306463-306480
33	CEBPB	chr3:306302-306792	HepG2	liver:	n/a	chr3:306309-306322 chr3:306463-306480
34	CEBPB	chr3:306331-306724	HepG2	liver:	n/a	chr3:306463-306480
35	CEBPB	chr3:242500-242742	K562	blood:	n/a	n/a
36	CEBPB	chr3:243949-244303	HepG2	liver:	n/a	chr3:244109-244120
37	CEBPB	chr3:242454-242771	H1-hESC	embryonic stem cell:	n/a	n/a
38	CEBPB	chr3:306264-306872	IMR90	lung:	n/a	chr3:306309-306322 chr3:306463-306480
39	CEBPB	chr3:302689-302981	Hela-S3	cervix:	n/a	chr3:302812-302825
40	CEBPB	chr3:279120-279410	A549	lung:	n/a	chr3:279226-279239 chr3:279227-279238
41	CEBPB	chr3:306282-306969	HepG2	liver:	n/a	chr3:306309-306322 chr3:306463-306480
42	CEBPB	chr3:291612-291803	H1-hESC	embryonic stem cell:	n/a	chr3:291705-291716
43	CEBPB	chr3:244050-244226	H1-hESC	embryonic stem cell:	n/a	chr3:244109-244120
44	CEBPB	chr3:306243-306864	HepG2	liver:	n/a	chr3:306309-306322 chr3:306463-306480
45	CEBPB	chr3:243974-244307	A549	lung:	n/a	chr3:244109-244120
46	CEBPB	chr3:279116-279413	HepG2	liver:	n/a	chr3:279226-279239 chr3:279227-279238
47	CEBPD	chr3:306328-306607	HepG2	liver:	n/a	n/a
48	CHD1	chr3:239582-239589	GM12878	blood:	n/a	n/a
49	CHD1	chr3:239219-239240	H1-hESC	embryonic stem cell:	n/a	n/a
50	CHD1	chr3:238324-238476	H1-hESC	embryonic stem cell:	n/a	n/a

(count:1221 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:243996-244046	PANC-1	pancreas:	n/a
2	chr3:243996-244046	PANC-1	pancreas:	n/a
3	chr3:285234-285284	Jurkat	blood:	n/a
4	chr3:239229-239279	SK-N-SH	brain:	n/a
5	chr3:238496-238546	ovcar-3	ovarian:	n/a
6	chr3:238048-238098	NHDF-neo	bronchial:	n/a
7	chr3:238496-238546	A549	lung:	n/a
8	chr3:238615-238665	HRPEpiC	eye:	n/a
9	chr3:239207-239257	ProgFib	skin:	n/a
10	chr3:239207-239257	NHBE	bronchial:	n/a
11	chr3:238611-238661	LNCaP	prostate:	n/a
12	chr3:239665-239715	GM19239	blood:	n/a
13	chr3:239188-239238	SK-N-MC	brain:	n/a
14	chr3:238615-238665	SK-N-SH_RA	brain:	n/a
15	chr3:241182-241232	NHDF-neo	bronchial:	n/a
16	chr3:239188-239238	Jurkat	blood:	n/a
17	chr3:238496-238546	H1-hESC	embryonic stem cell:	embryo
18	chr3:240139-240189	NT2-D1	testis:	n/a
19	chr3:240139-240189	Caco-2	colon:	n/a
20	chr3:238392-238442	HCF	heart:	n/a
21	chr3:239733-239783	HRPEpiC	eye:	n/a
22	chr3:238618-238668	AG04449	skin:	fetal
23	chr3:239207-239257	PANC-1	pancreas:	n/a
24	chr3:238611-238661	HEEpiC	esophagus:	n/a
25	chr3:271185-271235	HNPCEpiC	eye:	n/a
26	chr3:238618-238668	HRCEpiC	kidney:	n/a
27	chr3:238161-238211	Caco-2	colon:	n/a
28	chr3:238318-238368	HEEpiC	esophagus:	n/a
29	chr3:238392-238442	HCT-116	colon:	n/a
30	chr3:239188-239238	HEEpiC	esophagus:	n/a
31	chr3:240139-240189	NHBE	bronchial:	n/a
32	chr3:238048-238098	HMEC	breast:	n/a
33	chr3:239188-239238	GM12878	blood:	n/a
34	chr3:239506-239556	NB4	blood:	n/a
35	chr3:241182-241232	HAEpiC	amniotic membrane:	n/a
36	chr3:239188-239238	ovcar-3	ovarian:	n/a
37	chr3:239665-239715	ECC-1	luminal epithelium:	n/a
38	chr3:239665-239715	U87	brain:	n/a
39	chr3:238392-238442	RPTEC	kidney:	n/a
40	chr3:238161-238211	BJ	skin:	n/a
41	chr3:238496-238546	HCT-116	colon:	n/a
42	chr3:241182-241232	U87	brain:	n/a
43	chr3:239188-239238	Caco-2	colon:	n/a
44	chr3:238161-238211	HepG2	liver:	n/a
45	chr3:238496-238546	SK-N-MC	brain:	n/a
46	chr3:238615-238665	ECC-1	luminal epithelium:	n/a
47	chr3:243996-244046	RPTEC	kidney:	n/a
48	chr3:239733-239783	Caco-2	colon:	n/a
49	chr3:239506-239556	PFSK-1	brain:	n/a
50	chr3:238611-238661	HCF	heart:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:291331..293955-chr3:294697..297452,2	MCF-7	breast:
2	chr3:291331..293955-chr3:294697..297452,2	MCF-7	breast:
3	chr3:297411..299702-chr3:300779..302869,2	K562	blood:
4	chr3:297411..299702-chr3:300779..302869,2	K562	blood:

(count:24 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-IL5RA-6	chr3:237441-237597	ENSG00000224318.1
2	lnc-CNTN6-7	chr3:288251-290282	NONHSAT087561
3	lnc-CNTN6-7	chr3:254887-255362	NONHSAT087562
4	lnc-CNTN6-7	chr3:239326-239775	NONHSAT087561
5	lnc-IL5RA-6	chr3:237441-237597	ENSG00000224318.1
6	lnc-IL5RA-6	chr3:238139-238386	NONHSAT087559
7	lnc-CNTN6-7	chr3:288251-288539	NONHSAT087560
8	lnc-CNTN6-7	chr3:286296-286375	NONHSAT087560
9	lnc-CNTN6-7	chr3:238454-238746	NONHSAT087560
10	lnc-CNTN6-7	chr3:286296-286375	NONHSAT087561
11	lnc-IL5RA-6	chr3:237679-237723	ENSG00000224318.1
12	lnc-IL5RA-6	chr3:237679-237723	ENSG00000224318.1
13	lnc-IL5RA-6	chr3:238139-238191	ENSG00000224318.1
14	lnc-IL5RA-6	chr3:238290-238542	ENSG00000224318.1
15	lnc-CNTN6-7	chr3:239697-239775	NONHSAT087562
16	lnc-IL5RA-6	chr3:237679-237723	ENSG00000224318.1
17	lnc-IL5RA-6	chr3:237441-237597	ENSG00000224318.1
18	lnc-IL5RA-6	chr3:238650-239024	ENSG00000224318.1
19	lnc-IL5RA-6	chr3:238650-238882	ENSG00000224318.1
20	lnc-IL5RA-6	chr3:238139-238191	ENSG00000224318.1
21	lnc-IL5RA-6	chr3:237679-237723	NONHSAT087559
22	lnc-IL5RA-6	chr3:238139-238191	ENSG00000224318.1
23	lnc-IL5RA-6	chr3:237540-237597	NONHSAT087559
24	lnc-IL5RA-6	chr3:238290-238385	ENSG00000224318.1

No data

Variant related genes	Relation type
CHL1-AS2	TF binding region
CHL1	TF binding region
CHL1-AS2	CpG island
CHL1	CpG island

Extended variants
information (count: 3811 )
Associated
traits (count: 85 )

Variant overlapped rSNPs/rCNVs (count:3811 , 50 per page) page: 1 2 3 4 5 6 7 ... 77

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1516338	chr3:236759-236760	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs566220812	chr3:236764-236765	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs184721917	chr3:236780-236781	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs1516339	chr3:236799-236800	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs566887984	chr3:236803-236804	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs537282594	chr3:236814-236815	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs370966300	chr3:236818-236819	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs556160135	chr3:236824-236825	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs58886244	chr3:236827-236828	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs190041520	chr3:236841-236842	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs543618041	chr3:236864-236865	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs141157350	chr3:236879-236880	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs540097024	chr3:236885-236886	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs386657250	chr3:236888-236889	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs58166467	chr3:236889-236890	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs397707393	chr3:236890-236891	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs573380710	chr3:236893-236894	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs57933859	chr3:236894-236895	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs79515623	chr3:236903-236904	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs574057047	chr3:236919-236920	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs5845950	chr3:236923-236924	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs76161688	chr3:236940-236941	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs140535570	chr3:236977-236978	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs150459904	chr3:236996-236997	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs59201974	chr3:237004-237005	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs397962716	chr3:237007-237008	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs545270143	chr3:237013-237014	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs560272451	chr3:237023-237024	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs1516340	chr3:237075-237076	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
30	rs142881085	chr3:237076-237077	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs73088627	chr3:237120-237121	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs531188749	chr3:237121-237122	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs550088656	chr3:237123-237124	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs144977656	chr3:237137-237138	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs151079321	chr3:237159-237160	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs75583205	chr3:237164-237165	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs116445496	chr3:237196-237197	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs532316787	chr3:237207-237208	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs111552257	chr3:237209-237210	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs534312759	chr3:237227-237228	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs181521841	chr3:237258-237259	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs142069763	chr3:237277-237278	Enhancers Active TSS Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs574117537	chr3:237323-237324	Enhancers Active TSS Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs371386891	chr3:237328-237329	Enhancers Active TSS Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs537842948	chr3:237384-237385	Enhancers Active TSS Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs556864524	chr3:237396-237397	Enhancers Active TSS Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs578193962	chr3:237424-237425	Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs545647001	chr3:237433-237434	Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs184656121	chr3:237434-237435	Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs62228270	chr3:237439-237440	Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:85)

Disease	PMID	Source
Cancer	20164920	CNVD
Lung cancer	16618734	CNVD
Autism	18349135	CNVD
Breast cancer	20409316	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Intellectual disability	22045946	CNVD
Squamous cell cancer	19607727	CNVD
Gastric adenocarcinoma	19115996	CNVD
sporadic birth defects	19047251	CNVD
Mental retardation	17124404	CNVD
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Sudden cardiac death	19188705	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ovarian cancer	21720365	CNVD
Neuroblastoma	18923191	CNVD
Papillary thyroid carcinoma	21436994	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Breast cancer	17603634	CNVD
Neuroblastoma	17327916	CNVD
Glioblastoma multiforme	21080181	CNVD
Colorectal cancer	21297112	CNVD
Lynch syndrome	18415027	CNVD
Renal cell carcinoma	18592004	CNVD
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	20967226	CNVD
Autism	22543975	CNVD
Attention deficit hyperactivity disorder	19546859	CNVD
lymphocytic leukemia	21291569	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	17289997	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Tetralogy of Fallot	22912587	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	20685689	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:588 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:235800-237000	Enhancers	Ovary	ovary
2	chr3:236000-236800	Enhancers	Fetal Brain Female	brain
3	chr3:236200-237800	Enhancers	Breast Myoepithelial Primary Cells	Breast
4	chr3:236400-237000	Enhancers	Brain Germinal Matrix	brain
5	chr3:236400-237400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
6	chr3:236400-238200	Weak transcription	Spleen	Spleen
7	chr3:236600-237200	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
8	chr3:236600-237200	Flanking Active TSS	Fetal Brain Male	brain
9	chr3:236800-238000	Active TSS	Fetal Brain Female	brain
10	chr3:237000-237200	Active TSS	Brain Germinal Matrix	brain
11	chr3:237000-237800	Enhancers	Cortex derived primary cultured neurospheres	brain
12	chr3:237000-237800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
13	chr3:237000-240400	Active TSS	Ovary	ovary
14	chr3:237200-237400	Flanking Active TSS	Brain Germinal Matrix	brain
15	chr3:237200-237600	Active TSS	Brain Cingulate Gyrus	brain
16	chr3:237200-237800	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
17	chr3:237200-240000	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
18	chr3:237200-240200	Active TSS	Brain Anterior Caudate	brain
19	chr3:237200-241000	Active TSS	Brain Angular Gyrus	brain
20	chr3:237200-241000	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
21	chr3:237200-241000	Active TSS	Fetal Brain Male	brain
22	chr3:237400-237600	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
23	chr3:237400-241200	Active TSS	Brain Inferior Temporal Lobe	brain
24	chr3:237600-237800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
25	chr3:237600-237800	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
26	chr3:237600-240000	Bivalent/Poised TSS	Brain Germinal Matrix	brain
27	chr3:237600-240200	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
28	chr3:237600-241200	Bivalent/Poised TSS	Brain Cingulate Gyrus	brain
29	chr3:237800-238000	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
30	chr3:237800-238000	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
31	chr3:237800-238000	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
32	chr3:237800-238000	Active TSS	Brain Substantia Nigra	brain
33	chr3:237800-238200	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
34	chr3:237800-238200	Bivalent Enhancer	Primary B cells from cord blood	blood
35	chr3:237800-238200	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
36	chr3:237800-238200	Bivalent Enhancer	NHEK	skin
37	chr3:237800-238400	Flanking Bivalent TSS/Enh	Brain Hippocampus Middle	brain
38	chr3:237800-238600	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
39	chr3:237800-238600	Bivalent/Poised TSS	Fetal Kidney	kidney
40	chr3:237800-240200	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
41	chr3:237800-240200	Bivalent/Poised TSS	Duodenum Mucosa	Duodenum
42	chr3:237800-240400	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
43	chr3:237800-240400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
44	chr3:237800-240400	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
45	chr3:237800-240400	Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
46	chr3:237800-240400	Flanking Active TSS	Adipose Nuclei	Adipose
47	chr3:237800-240400	Active TSS	Pancreatic Islets	Pancreatic Islet
48	chr3:237800-240400	Active TSS	Rectal Mucosa Donor 29	rectum
49	chr3:237800-240400	Active TSS	Right Atrium	heart
50	chr3:237800-240600	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links